Catheter Precision (VTAK) has released an update to notify the public and investors about the unregistered sales of equity securities.
On January 24, 2024, Catheter Precision, Inc. converted 875 shares of its Series A Convertible Preferred Stock into 546,776 shares of common stock, with each preferred share converting into approximately 625 common shares. This private placement transaction was exempt under Section 3(a)(9) of the Securities Act of 1933, with no commissions paid for the exchange, and the newly issued common stock is registered for resale.
For further insights into VTAK stock, check out TipRanks’ Stock Analysis page.
